International Flavors & Fragrances IFF
- Employees
- 21,500
- Headquarters
- New York, NY
- CEO
- J. Erik Fyrwald
- Next results
- around Feb 10, 2027
Where each dollar of revenue went, FY2024
Revenue of $11.5B through the costs to a net profit of $263.0M · income statement of the 10-K
IFF among Materials peers
Six ratios from the latest 10-K. Each corner is the share of 23 peers the company is above, not a score.
What changed
24 new risk paragraphs and 2 accounting facts worth reading about. 10-K filed Feb 27, 2026 against Feb 28, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
2facts worth reading about the other 9 checks found nothing to note
-
Receivables growing faster than revenueReceivables +6.6% vs revenue -5.2% (+11.8 pts)
-
Inventory growing faster than revenueInventory +5.3% vs revenue -5.2% (+10.4 pts)
-
Cash from operations $850.0M vs net income −$359.0M (FY ending Dec 31, 2025)
8 more checks with nothing to note
-
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No longer listed: Goodwill Impairment Assessments - Nourish and Health & Biosciences Reporting Units
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
24 paragraphs in Risk Factors that were not in the 10-K filed Feb 28, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
Many of our products are ingredients or components in consumer products which are sold to end-users throughout the world. Demand for such consumer products depends on consumer preferences that are driven by a variety of factors, such as the increasing use of weight management pharmaceutical products, increasing health and wellness…
-
Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
We face intense global competition from multinational and specialized companies across our product offerings, as well as consumer product companies developing their own alternatives. Competitors may have greater resources, proprietary technologies, or benefit from recent industry consolidation, enabling them to respond more effectively…
-
Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
As part of our strategic transformation and portfolio optimization, we have completed several divestitures in recent years and continue to evaluate additional transactions, including strategic alternatives for our Food Ingredients segment. Successfully completing such transactions depends on factors beyond our control, such as industry…
-
Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
We manage inventory based on shelf life, sourcing levels, and anticipated demand. Effective inventory control is critical to meeting customer needs without incurring excess storage costs. If we fail to accurately forecast customer demand, it may lead
New risk paragraphs, against peers
Latest 10-K of each, Materials companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $12.4B | $11.5B | $11.5B | $10.9B |
| Net income | −$1.9B | −$2.6B | $263.0M | −$361.0M |
| Operating cash flow | $397.0M | $1.5B | $1.1B | $850.0M |
| Free cash flow | −$107.0M | $952.0M | $607.0M | $256.0M |
Revenue, FY2016 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$10.9B ▼ 5.2% in FY2025−$361.0M in FY2025$256.0M ▼ 57.8% in FY2025
Recent filings
3 filings in the last 30 days · SEC EDGAR
-
8-KNov 3, 2026Quarterly results 8-K item 2.02
-
8-KNov 3, 2026Director or officer change, Bylaws or fiscal year changed 8-K items 5.02, 5.03
-
10-QNov 3, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
International Flavors & Fragrances, New York, NY · from the 10-K filed Feb 27, 2026
We are a leading creator and manufacturer of products for application in food, beverage, health & biosciences, and scent, as well as complementary adjacent products, including natural health ingredients, all of which are used in a wide variety of consumer and end-use products. Our products are sold principally to manufacturers of dairy, meat, beverages, snacks, savory, sweet, baked goods, grain processors and other foods, personal care products, soaps and detergents, cleaning products, perfumes, dietary supplements, food protection, infant, elderly and animal nutrition, functional food, bio-fuel, and oral care products.
- Headquarters
- New York, NY
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Nov 3, 2026
- Incorporated in
- NY
Employees, at the top of the page: "As of December 31, 2025, we had approximately 21,500 employees worldwide, of whom approximately 5,500 are employed in the United States" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 27, 2026 (open at SEC), compared with the 10-K filed Feb 28, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IFF/export.csv") into a cell.